awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34854658-F7F931D4-C66E-4CFB-B82E-F5CA5EF06213
Q34854658-F7F931D4-C66E-4CFB-B82E-F5CA5EF06213
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34854658-F7F931D4-C66E-4CFB-B82E-F5CA5EF06213
Antiangiogenic agents in combination with chemotherapy in patients with advanced non-small cell lung cancer.
P2860
Q34854658-F7F931D4-C66E-4CFB-B82E-F5CA5EF06213
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34854658-F7F931D4-C66E-4CFB-B82E-F5CA5EF06213
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4aeeac63813632015cdce2726b29ff24059434dd
P2860
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.